Cargando…

Expression of Concern to: Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases

Detalles Bibliográficos
Autores principales: Polansky, Hanan, Itzkovitz, Edan, Javaherian, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365573/
https://www.ncbi.nlm.nih.gov/pubmed/30725243
http://dx.doi.org/10.1186/s40169-019-0222-0
_version_ 1783393450090037248
author Polansky, Hanan
Itzkovitz, Edan
Javaherian, Adrian
author_facet Polansky, Hanan
Itzkovitz, Edan
Javaherian, Adrian
author_sort Polansky, Hanan
collection PubMed
description
format Online
Article
Text
id pubmed-6365573
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-63655732019-02-27 Expression of Concern to: Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases Polansky, Hanan Itzkovitz, Edan Javaherian, Adrian Clin Transl Med Correction Springer Berlin Heidelberg 2019-02-06 /pmc/articles/PMC6365573/ /pubmed/30725243 http://dx.doi.org/10.1186/s40169-019-0222-0 Text en © Springer-Verlag GmbH Germany, Part of Springer Nature 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Correction
Polansky, Hanan
Itzkovitz, Edan
Javaherian, Adrian
Expression of Concern to: Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases
title Expression of Concern to: Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases
title_full Expression of Concern to: Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases
title_fullStr Expression of Concern to: Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases
title_full_unstemmed Expression of Concern to: Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases
title_short Expression of Concern to: Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases
title_sort expression of concern to: clinical study of gene-eden-vir/novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365573/
https://www.ncbi.nlm.nih.gov/pubmed/30725243
http://dx.doi.org/10.1186/s40169-019-0222-0
work_keys_str_mv AT polanskyhanan expressionofconcerntoclinicalstudyofgeneedenvirnoviriningenitalherpessuppressivetreatmentsafelydecreasesthedurationofoutbreaksinbothsevereandmildcases
AT itzkovitzedan expressionofconcerntoclinicalstudyofgeneedenvirnoviriningenitalherpessuppressivetreatmentsafelydecreasesthedurationofoutbreaksinbothsevereandmildcases
AT javaherianadrian expressionofconcerntoclinicalstudyofgeneedenvirnoviriningenitalherpessuppressivetreatmentsafelydecreasesthedurationofoutbreaksinbothsevereandmildcases